A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2002
10/29/2002	US6472200 In vivo organ architecture (organ structure) of organ units (e.g., acinus of liver) is maintained within each indivisual micro-organ culture and the cultures being loacted within the chamber, in contact with fluid flowing through chamber
10/29/2002	US6472172 DNA encoding a novel human inhibitor-of-apoptosis protein
10/29/2002	US6472162 Obtaining blood from a patient, sequestering plasma, adding ethanol in a concentration fo 8-20% to prepare a solution containing prothrombin, converting to thrombin, filtering and applying to a patient
10/29/2002	US6472140 α-2- macroglobulin therapies and drug screening methods for Alzheimer's disease.
10/29/2002	US6471993 Microstructure having voids located within said semi-solid network; tissue engineering scaffolds
10/29/2002	US6471965 Herpes simplex virus, human cytomegalovirus, epstein-barr virus
10/29/2002	CA2221242C Viral agent associated with mystery swine disease
10/24/2002	WO2002084281A1 Encapsulated cell indicator system
10/24/2002	WO2002083956A1 Compositions and methods for the therapy and diagnosis of breast cancer
10/24/2002	WO2002083928A2 Nucleid acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/24/2002	WO2002083926A2 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	WO2002083917A2 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer
10/24/2002	WO2002083916A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	WO2002083878A1 Method for autologous transplantation
10/24/2002	WO2002083864A2 Methods and reagents for cell transplantation
10/24/2002	WO2002083187A1 Systems and methods for inducing mixed chimerism
10/24/2002	WO2002083157A1 Blood group-free human blood plasma and the preparation method thereof
10/24/2002	WO2002083152A1 Activation of natural killer cells by adenosine a3 receptor agonists
10/24/2002	WO2002083116A1 Methods of treating prion disease in mammals comprising administering a chaotropic agent such as guanidine, urea or potassium iodide
10/24/2002	WO2002082904A2 Method of treating or retarding the development of blindness
10/24/2002	WO2002064057A3 Use of cell penetrating peptides to generate antitumor immunity
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002056830A3 The use of immature dendritic cells to silence antigen specific cd8+t cell function
10/24/2002	WO2002054873A3 Microbiological agents for the control of sea lice
10/24/2002	WO2002032397A9 Electroprocessing in drug delivery and cell encapsulation
10/24/2002	WO2002030467A3 Pharmaceutical composition containing honey for the treatment of wounds
10/24/2002	WO2002026258A3 Treatment of immune-mediated diseases by oral administration of plasma fractions
10/24/2002	WO2002017935A3 A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
10/24/2002	WO2001068135A9 Compositions and methods for affecting osteogenesis
10/24/2002	WO2001059073A9 Cytotoxic t lymphocytes activated by dendritic cell hybrids
10/24/2002	WO2001058526A9 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
10/24/2002	WO2001055348A9 Improved inhibition of graft versus host disease
10/24/2002	WO2001053465A9 Human embryoid body-derived cells
10/24/2002	US20020157121 Propagation of human hepatocytes in non-human animals
10/24/2002	US20020156039 Sal2 has a tumor suppressive effect; Sal2 may also be used as an anti-viral agent that interferes with the ability of a DNA tumor virus to replicate in a cell
10/24/2002	US20020156031 A DNA segment comprising a protein coding region encoding an Osterix polypeptide; gene therapy; osteoporosis; recombinant Osterix polypeptide
10/24/2002	US20020155997 Biologically active material isolated from non-pathogenic bacteria, such as Enterobacteriaceae
10/24/2002	US20020155613 Recovering leucocyte components from human blood; obtain cells, break cells, separate leukocyte components, recover components
10/24/2002	US20020155609 Monocyte-specific particulate delivery vehicle
10/24/2002	US20020155601 Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same
10/24/2002	US20020155598 Generating insulin secreting cells; obtain mammalian pancreatic tissues, dissociate cells, dedifferentiate into insulin precursor cells, isolate and propagate cells
10/24/2002	US20020155597 In vivo production and delivery of erthropoietin or insulinotropin for gene therapy
10/24/2002	US20020155577 Compound for use in the treatment of parkinson's disease
10/24/2002	US20020155559 Solid support for the generaton and propagation of preferential tissues
10/24/2002	US20020155529 Viral vectors having reduced virulence
10/24/2002	US20020155511 Novel antibody compositions for the negative selection of specific rat leukocyte subsets
10/24/2002	US20020155454 Miniribozymes active at low magnesium ion concentrations
10/24/2002	US20020155447 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/24/2002	US20020155432 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/24/2002	US20020155171 Mixtures of peptide, minerals and vitamins
10/24/2002	US20020155122 Immunologically significant herpes simplex virus antigens and methods for identifying and using same
10/24/2002	US20020155111 For the vaccination of patients having malignant B cell diseases
10/24/2002	US20020155107 Methods and formulations for reducing circulating antibodies
10/24/2002	US20020155101 Cardiac arrhythmia treatment methods
10/24/2002	US20020155100 Compositions and methods for regulated protein expression in gut
10/24/2002	US20020155098 Methods for treating the inflammatory component of a brain disorder
10/24/2002	US20020155096 Mixing stem cell preparation with a physiologically acceptable matrix material to form a stem cell matrix; incubating the stem-cell matrix in vitro prior to use in tissue or organ treatment or repair
10/24/2002	EP1242157A4 Methods for preparing blood or plasma component solutions with improved concentrations
10/24/2002	DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway
10/24/2002	CA2444548A1 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions
10/24/2002	CA2444004A1 Method for autologous transplantation
10/24/2002	CA2443993A1 Methods and reagents for cell transplantation
10/24/2002	CA2443984A1 Encapsulated cell indicator system
10/24/2002	CA2443900A1 Methods of treating prion disease in mammals comprising administering a chaotropic agent such as guanidine, urea or potassium iodide
10/24/2002	CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
10/24/2002	CA2442670A1 Method of treating or retarding the development of blindness
10/23/2002	EP1250929A1 Virus-free plasma protein compositions treated with porous membrane and process for producing the same
10/23/2002	EP1250918A1 Cosmetic compositions containing archaebacteria extracts
10/23/2002	EP1250594A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof
10/23/2002	EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer
10/23/2002	EP1250430A2 Regulatory sequence for the specific expression in dendritic cells and uses thereof
10/23/2002	EP1250425A2 Secreted human proteins, polynucleotides encoding them and methods of using the same
10/23/2002	EP1250421A1 Recombinant flaviviruses and methods of use thereof
10/23/2002	EP1250420A2 Techniques for growth and differentiation of human pluripotent stem cells
10/23/2002	EP1250358A1 Therapeutic peptides
10/23/2002	EP1250161A2 Polymer blends as biodegradable matrices for preparing biocomposites
10/23/2002	EP1250155A1 Angiogenesis and vascular permeability modulators and inhibitors
10/23/2002	EP1250152A1 Hyaluronic acid in the treatment of cancer
10/23/2002	EP1250146A2 Use of neurotoxins for treating diabetes
10/23/2002	EP1250143A2 Reduction in bacterial colonization by administering bacteriophage compositions
10/23/2002	EP1250116A1 Pharmaceutical and cosmetic carrier or composition for topical application
10/23/2002	EP1250055A1 Immune modulation with death receptor-induced apoptosis
10/23/2002	EP1250053A2 Method for produce sanitation using bacteriophages
10/23/2002	EP1250050A2 Method and device for sanitation using bacteriophages
10/23/2002	EP1159966B1 Composition for the treatment of psoriasis
10/23/2002	EP1150702B1 Use of orosomucoid for the production of a pharmaceutical preparation for the treatment of pancreatitis
10/23/2002	EP1144009B1 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
10/23/2002	EP1063891A4 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby
10/23/2002	EP0820293B1 Bioactive concentrate, its producing method and certain drug compositions containing also chondroitin sulphate
10/23/2002	CN1376201A Immunologically significant herpes simplex virus antigens
10/23/2002	CN1376197A Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
10/23/2002	CN1376196A Method for generating immune-compatible cells and tissues using nuclear transfer techniques
10/23/2002	CN1376073A Method of expressing antigen on the surface of an antigen-presenting cell by photochemical internalisation
10/23/2002	CN1376067A Conditioned cell culture medium compositions and method of use
10/23/2002	CN1375331A Antiphlogistic capsule capable of keeping the adverse energy downwards
10/23/2002	CN1375324A Capsule for treating arthralgia of extremities and its prepn. process
10/23/2002	CN1375314A Fermented soybean extracted liquid and composite medicine containing the said liquid
10/23/2002	CN1375313A Recipe and prepn. process of medicine for treating burns and scalds
10/23/2002	CN1375308A Chinese proprietary for treating protrusion of lumber interverterbral disc and its prepn.
10/23/2002	CN1375303A Ointment for dredging meridian passage and expelling wind-evil

1 ... 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 ... 1259